Allison Smego

Allison Smego, MD

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services Building

Salt Lake City
801-213-3599

  • Dr. Smego is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Utah. She earned her medical degree from the University of Cincinnati School of Medicine. She completed residency training in Pediatrics at Vanderbilt University and her Pediatric Endocrinology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Smego is board certified in General Pediatrics an board certified in subspecialty of Pediatric Endocrinology.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Endocrinology)
    National Board of Medical Examiners

  • Dr. Smego is an Assistant Professor of Pediatrics in the Division of Pediatric Endocrinology at the University of Utah. She earned her medical degree from the University of Cincinnati School of Medicine. She completed residency training in Pediatrics at Vanderbilt University and her Pediatric Endocrinology fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Smego is board certified in General Pediatrics an board certified in subspecialty of Pediatric Endocrinology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Diabetes & Endocrinology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Endocrinology)
    National Board of Medical Examiners

    Education history

    Fellowship Pediatrics Endocrinology - Department of Pediatrics, Division of Endocrinology, Cincinnati Children's Hospital Medical Center Chief Fellow
    Pediatric Endocrinology - Cincinnati Children's Hospital Medical Center Fellow
    Residency Pediatrics - Monroe Carell Jr. Children's Hospital at Vanderbilt Resident
    Medicine - University of Cincinnati College of Medicine M.D.
    Undergraduate Psychology & Pre-Medical Studies - University of Notre Dame B.A.

    Selected Publications

    Journal Article

    1. Ospelt E, Hardison H, Rioles N, Noor N, Weinstock R, Cossen K, Mathias P, Smego A, Methioudakis N, Ebekozien O (2023). Understanding Provider's Readiness and Attitudes Towards Autoantibody Screening: A Mixed-Methods Study. Clin Diabetes.
    2. Miyazaki B, Ebekozien O, Rompicherla S, Ohmer A, Guttman-Bauman I, Mucci A, Guarneri A, Raman V, Smego A, Dickinson JK (2023). Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults With Type 1 Diabetes and Coronavirus Disease 2019. Diabetes Spectr, 36(4), 398-402. (Read full article)
    3. Miyazaki B, Ebekozien O, Rompicherla S, Ohmer A, Guttman-Bauman I, Mucci A, Guarneri A, Raman V, Smego A, Dickinson, J (2023). Association Between Health Insurance Type and Adverse Outcomes for Children and Young Adults with Type 1 Diabetes and Coronavirus Disease 2019. Diabetes Spectrum, 36(4), 398-402.
    4. Lawson S, Redel JM, Smego A, Gulla M, Schoettker PJ, Jolly M, Mostajabi F, Hornung L (2020). Assessment of a Day Hospital Management Program for Children With Type 1 Diabetes. JAMA Netw Open, 3(3), e200347. (Read full article)
    5. Smego A, Lawson S, Courter JD, Warden D, Corathers S (2018). Decreasing the Time to Insulin Administration for Hospitalized Patients With Cystic Fibrosis-Related Diabetes. Hosp Pediatr, 8(5), 288-292. (Read full article)
    6. Smego A, Woo JG, Klein J, Suh C, Bansal D, Bliss S, Daniels SR, Bolling C, Crimmins NA (2017). High Body Mass Index in Infancy May Predict Severe Obesity in Early Childhood. J Pediatr, 183, 87-93.e1. (Read full article)
    7. Smego AR, Backeljauw P, Gutmark-Little I (2016). Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy. J Clin Endocrinol Metab, 101(5), 2084-8. (Read full article)

    Abstract

    1. Coletti M, Keene J, Smego A, Young M, Ostrander B (). Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Poster presentation at Child Neurology Society in Fall 2023.  [Abstract]. (Epub ahead of print)
    2. Coletti M, Keene J, Smego A, Young M, Ostrander B (). Endocrine, Ophthalmic and Developmental Outcomes of Children Prenatally Diagnosed with Midline Brain Defects. Presented at International Newborn Brain Conference Feb 2024 by lead author.  [Abstract]. (Epub ahead of print)
    3. Demeterco-Berggren, C, Jacobsen, L, Guttman-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Choudhary, A, Wong, J, Ebekozien, O (). Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among centers participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Poster Presentation at the 84th ADA Scientific Sessions. June 2024.  [Abstract]. (Epub ahead of print)
    4. Smego A, Asfour F, Sirstins J, Loizos C, Counter M, Whitaker B, Bjerregaard S, Wadhwa T, Gubler L, Raman V (2023). Increasing Pump Therapy Adoption in Patients with Type 1 Diabetes [Abstract]. 15(S1), 28-29.
    5. Jelley H, Mistry S, Meder M, Smego A, Raman V (2023). Health Inequities in the Use of Diabetes Technology Among Racial/Ethnic Minority Pediatric Patients with Type 1 Diabetes. Presented Pediatric Endocrine Society 2023. [Abstract]. 96(S3), 122-128.
    6. Jelley H, Mistry S, Meder M, Smego A, Raman V (2023). Possible Insulin Allergy Presenting with Anaphylaxis. Presented at Pediatric Endocrine Society 2023. [Abstract]. 96(S3), 122-128.
    7. Ospelt E, Hardison H, Rioles N, Noor N, Crossen S, Smego A, Aleppo G, Friedman J, Eng D, Sullivan C, Majidi S, Lorincz I, Ebekozien O (2023). Provider Perceptions of Barriers and Benefits to Type 1 Diabetes Autoantibody Testing Among Patients and Relatives. Poster Presentation at the 83rd ADA Scientific Sessions. June 2023.  [Abstract]. 72(S1), 1290.
    8. Morales Moreno J, Smego A, Stipleman C (2023). Risk-based Quality Improvement for Type 2 Diabetes Screening in Primary Care. American Pediatric Association, Region 9 & 10 Meeting.  Monterey, CA.  [Abstract].
    9. Meder M, Jelley H, Gallenberger M, Murray M, Zhang Y, Li H, Smego A (2022). Use of Basal-Bolus Subcutaneous Insulin in the Initial Management of Mild to Moderate Diabetic Ketoacidosis is Safe in Type 1 Diabetes.  [Abstract]. 95(Suppl 1), 76-77.
    10. Meder M, Jelley H, Smego A, Raman V, Raleigh Z (2022). Addison's Disease Presenting with Recurrent Pericardial Effusion and Cardiac Tamponade. [Abstract]. 95(Suppl 1), 17-18.
    11. Jelley H, Meder M, Murray M, Raman V, Raleigh Z, Foster C, Smego A, Kocolas I, Al-Hamad D (2021). Infantile hypophosphatasia as a cause of severe hypotonia and hypercalcemia. [Abstract]. 94(Suppl 2), 14-15.

    Video/Film/CD/Web/Podcast

    1. Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego A (2021). Diagnosis and Treatment of Pediatric Type 1 Diabetes. Care Process Model. Intermountain Healthcare. [Web]. Available: https://intermountainhealthcare.org/ckr-ext/Dcmnt?ncid=520451313.
    2. Galbraith BM, Jackson D, Murray M, Schunk J, Sims J, Sirstins J, Smego A (2021). Management and Treatment of Pediatric Type 2 Diabetes. Care Process Model. Intermountain Healthcare.  [Web]. Available: https://intermountainhealthcare.org/ckr-ext/Dcmnt?ncid=529163870.

  • News & Podcasts